| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bb3e925a1a6e16fc69cd7351d4e353e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-007 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 |
| filingDate |
2022-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f680e94758b6b15af5b6d6576707ac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2310e0946c80d2d25dcfad897797b911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8f27c15849d55c0f5065440545bd032 |
| publicationDate |
2022-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022231157-A1 |
| titleOfInvention |
Colon cancer-specific target exosome composition as drug carrier material, and use thereof |
| abstract |
The present invention relates to: a recombinant expression vector having inserted therein a gene expressing ligand which binds to a receptor of a colon cancer cell in a gene expressed by means of an extracellular vesicle of a stem cell; a pharmaceutical composition comprising an extracellular vesicle transformed by means of the expression vector; and a method for preparing the expression vector for preventing or treating colon cancer. The present invention has an advantage of utilizing an exosome, as an extracellular vesicle, as a drug carrier material to be selectively bound to a colon cancer cell which is a target cell, and enable a specific action targeting the colon cancer cell. |
| priorityDate |
2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |